None
Conditions
Interventions
Induction period half dose rapid injection group (Group A):Group A patients were intravenously injected with a mixture of propofol and remifentanil at a dose of 1/2 of the theoretical induction dose,
Quarter dose rapid injection group (Group B):Group B patients were intravenously injected with a mixture of propofol remifentanil at a dose of 1/4 of the theoretical induction dose, with a duration of
Constant speed pump injection group (Group C):Group C patients were intravenously injected with a mixture of propofol and remifentanil, and all theoretical induced doses were uniformly pumped at a spe
Sponsors
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients aged = 18 years but<80 years, who underwent both gastroscopy and colonoscopy, and ASA grades I-III voluntarily joined.
Exclusion criteria
Exclusion criteria: ? BMI>30kg/m2 ? Breathing air SpO2 < 95% ? Poor blood pressure control (systolic blood pressure = 180mmHg or diastolic blood pressure = 110mmHg) ? Ventricular rate<50 beats/min or malignant arrhythmia (ventricular fibrillation, ventricular tachycardia, preexcitation syndrome with atrial fibrillation, third degree atrioventricular block) ? Communication barriers ? History of drug allergies or allergies to eggs or soybeans
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of body movements (mild limb movements, hiccups, coughing, restlessness); | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of respiratory related adverse events (SpO230% basal blood pressure, heart rate<50bmp);Induction duration;Duration of gastroscopy examination;Awakening time;Dosage of anesthesia;Dosage of vasoactive drugs used;Vital signs; | — |
Countries
China
Contacts
Public ContactGe Jingwu
Jiangsu Provincial People's Hospital
Outcome results
None listed